Authors
Loading...
Randomized trial demonstrates improved drug-like properties in preclinical models, suggesting potential for epilepsy treatment.
Abram et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: